semaglutide .05 Ozempic 0.5mg Injection (Semaglutide) | GLP-1 Agonist for Type 2 Diabetes Control Ozempic 0.25 mg, 0.5 mg

Some patients remain symptomatic despite biochemically normal thyroid function tests, and a thorough review of thyroid management with an endocrinologist may be warranted before pursuing additional weight loss interventions

The primary purpose of these medications is to help people simplify their weight loss journeys

Our physicians may recommend holding at the current dose for an additional 2-4 weeks before advancing

Acknowledgements Thanks are given to Christian Tikkanen and Pierre Johansen, from Novo Nordisk, for reviewing model assumptions and providing feedback on a draft manuscript

50,51 The initial dosing regimen of tirzepatide is 2.5 mg weekly, with the dose increased to up to 15 mg weekly usually after one month at the previous dose